Skip to content

Use of Ulipristal Acetate in Induction of Second Trimester Missed Abortion

Use of Ulipristal Acetate in Induction of Second Trimester Missed Abortion in Women With Previous Caesarian Section: A Randomized Controlled Trial.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04989400
Enrollment
24
Registered
2021-08-04
Start date
2019-01-01
Completion date
2020-01-01
Last updated
2021-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of Second Trimester Abortion

Brief summary

The aim of this work is to assess the effectiveness and safety of Ulipristal Acetate in the management of 2nd trimester missed abortion along with misoprostol in pregnant women with previous caesarean section versus the use of misoprostol only with placebo as regards the time needed for abortion,Hypothesis: In pregnant women with 2nd trimester missed abortion with previous caesarean section , Ulipristal Acetate may decrease the time interval to achieve abortion when combined with Misoprostol in comparison to misoprostol alone.the included women divided to 2 groups Group A: will receive Ulipristal acetate 30mg, starting misoprostol 12 hours later 100µg every 6 hours buccal according to FIGO guidelines 2017.Group B: will receive placebo then 12 hours later start misoprostol 100µg every 6 hours buccal according to FIGO guidelines 2017. then we assess Induction-to-abortion interval time.

Interventions

DRUGUlipristal Acetate

Group A: received Ulipristal acetate 30mg, starting misoprostol 12 hours later 100µg every 6 hours buccal. Then women in had rest for 24 hours after 5 doses of misoprostol and restarted misoprostol-only in both groups with the same above regimens, repeating the same sequence for two weeks unless there was excessive bleeding or infection or uterine contractions or cervical changes. If failed, patient proceeded to hysterotomy. If patient aborted, an obstetric US was done to assess the presence of remnants in the uterine cavity. Patient with remnants of conception proceeded suction evacuation.

DRUGMisoprostol

Group A: received Ulipristal acetate 30mg, starting misoprostol 12 hours later 100µg every 6 hours buccal.Group B: received placebo tablet of same shape , texture of that of ulipristal then 12 hours later start misoprostol 100µg every 6 hours buccal. Then women in both groups had rest for 24 hours after 5 doses of misoprostol and restarted misoprostol-only in both groups with the same above regimens, repeating the same sequence for two weeks unless there was excessive bleeding or infection or uterine contractions or cervical changes. If failed, patient proceeded to hysterotomy. If patient aborted, an obstetric US was done to assess the presence of remnants in the uterine cavity. Patient with remnants of conception proceeded suction evacuation.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

• Women with 2nd trimester missed abortions * Gestational age 13-26 weeks. * Women with a previous caesarian section scar,(para 1cs till para 4 cs). * Women counseled and chose medication abortion rather than surgical evacuation

Exclusion criteria

* Women with an accompanying medical disorder such as: Preeclampsia, Diabetes Mellitus or Heart disease. * Primigravida women or non scarred uterus. * Women with previous myomectomy or hysterotomy scar or upper segment caesarean section scar. * Induction of abortion in women with congenital fetal malformations or positive fetal pulsations due to medical disorder. * Women with placenta previa . * Allergy or contraindications to either Ulipristal acetate or Misoprostol. * Women with inevitable abortion in the form of vaginal bleeding or uterine contractions

Design outcomes

Primary

MeasureTime frameDescription
Induction-to-abortion interval time.2 weekscalculate the time needed from start of intervention till abortion occured

Secondary

MeasureTime frameDescription
complete evacuation between both groups2 weeksnumber of patients experienced complete abortion between both groups
need for hysterotomy2 weeksnumber of patients underwent hysterotomy

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026